Background: There is growing interest in white matter (WM) imaging with positron emission tomography (PET). Objectives: We studied the association of cognitive function in late multiple sclerosis (MS) with cortical and WM Pittsburgh compound-B PET (PiB-PET) binding. Methods: In the population-based Mayo Clinic Study of Aging, 24 of 4869 participants had MS (12 underwent PiB-PET). Controls were age and sex matched (5:1). We used automated or semi-automated processing for quantitative image analyses and conditional logistic regression for group differences. Results: MS patients had lower memory (p = 0.03) and language (p = 0.02) performance; smaller thalamic volumes (p = 0.003); and thinner temporal (p = 0.001) and frontal (p = 0.045) cortices on magnetic resonance imaging (MRI) than controls. There was no difference in global cortical PiB standardized uptake value ratios between MS and controls (p = 0.35). PiB uptake was lower in areas of WM hyperintensities compared to normal-appearing white matter (NAWM) in MS (p = 0.0002). Reduced PiB uptake in both the areas of WM hyperintensities (r = 0.65; p = 0.02) and NAWM (r = 0.69; p = 0.01) was associated with decreased visuospatial performance in MS. Conclusion: PiB uptake in the cortex in late MS is not different from normal age-matched controls. PiB uptake in the WM in late MS may be a marker of the large network structures' integrity such as those involved in visuospatial performance.
Introduction
Cognitive impairment affects more than half of the patients with multiple sclerosis (MS) including "benign MS" 1 and can be observed even in the early clinically isolated syndrome phase of the disease. 2 Gray matter (GM) atrophy and high white matter (WM) and GM lesion loads are the core correlates of cognitive dysfunction in MS. 3, 4 Neurodegeneration starts early in MS. As such, atrophy of the thalamus, the largest deep GM relay of the brain, can be observed in all ages including the earliest asymptomatic phase of MS (i.e. radiologically isolated syndrome (RIS)) and worsens with time even in the absence of overt cognitive impairment. 5 Little is known about the imaging correlates of cognitive performance variation outside of overt impairment in MS. Studying late MS may allow one to compare cognitive health in MS to other age-dependent causes of WM pathology.
Mild cognitive impairment (MCI) in older adults is commonly associated with cortical atrophy and deposition of β-amyloid, which is a pathological hallmark for Alzheimer's disease (AD). 6 Therefore, cognitive difficulties in late MS could potentially be associated with β-amyloid deposition as well.
[11C] Pittsburgh compound-B (PiB) is a tracer that binds to fibrillary β-amyloid with high affinity and is used in quantifying cortical β-amyloid plaques. 7 Advanced magnetic resonance imaging (MRI) techniques (e.g. diffusion tensor imaging) targeting the myelin component of brain parenchyma 8 are not entirely myelin specific. Intracellular and extracellular water, axons, and inflammatory infiltrates can contribute to this lack of specificity. 9 In contrast, several β-amyloid tracers including PiB can target myelin and bind to WM as an off-target phenomenon independent of cortical β-amyloid deposition. 7, [10] [11] [12] [13] Here, we studied the cortical β-amyloid load, WM PiB binding, cortical thickness, thalamic volume, and cognitive performance in patients with late MS compared to controls.
Materials and methods

Study population and consent
We studied individuals enrolled in the Mayo Clinic Study of Aging (MCSA), a prospective populationbased study of cognitive aging 14 (see supplement) ( Figure 1 ). Of the 4869 MCSA participants between 2004 and 2015, 24 (0.5%) patients were previously diagnosed with MS. Diagnosis was confirmed with the most recent diagnostic criteria 15 using expert clinical review by a neurologist (B.Z.) and an MS specialist (O.H.K.). Each MS patient was age and sex matched to five controls without a demyelinating disease, MCI, or dementia diagnosis from the same cohort.
The study protocol was approved by the Mayo Clinic and Olmsted Medical Center Institutional Review Boards. Every participant signed informed consent.
Neuropsychological testing
The neuropsychological battery assessed four cognitive domains of memory, language, attention-executive function, and visuospatial skills to calculate z-scores for individual tests', cognitive domains', and a global cognitive z-score as previously described 14 (see supplement).
MRI acquisition and analyses
A standardized MRI imaging protocol was performed on 3.0-T MRI scanners (GE Healthcare). A T1-weighted 3D magnetization-prepared rapid acquisition gradient-echo sequence and an axial T2-weighted fluid-attenuated inversion recovery (FLAIR) sequence with an in-plane resolution of 0.86 mm × 0.86 mm and a slice thickness of 3.6 mm (2.66 mm 3 resolution) were included in the protocol.
Previously described and validated structural MRI techniques of cortical thickness estimates from FreeSurfer (version 5.3) 16 and thalamic volume estimates using an SPM12-based analysis 17 were used. White matter hyperintensities (WMH) were quantified using a semi-automated segmentation algorithm on FLAIR as previously described 18 (see supplement).
PiB-PET acquisitions and analyses
Positron emission tomography (PET) imaging was performed on a PET/CT scanner (DRX; GE Healthcare) operating in three-dimensional mode. After the injection of [11C] PiB (292-729 MBq) and after a 40-minute uptake period, a 20-minute PiB scan was acquired at 40-60 minutes post-injection acquisition of four 5-minute dynamic frames. Dynamic PET images were generated (256 matrix, 300 mm field of view, 1.17 mm × 1.17 mm × 3.27 mm voxel size, 4.48 mm 3 resolution) using an iterative reconstruction algorithm. Standard corrections for attenuation, scatter, randoms, and decay were applied as well as a 5-mm Gaussian post-filter. The images from the four dynamic frames were averaged to create a single static image. Previous data have shown that a 40-to 60-minute PiB acquisition has statistically equivalent accuracy in detecting PiB retention as compared to dynamic arterial sampling, carotid input sampling, and delay-plateau phase acquisition periods ranging in total duration from 20 to 50 minutes. 19 An automated image-processing pipeline, which includes registration of the PET image volume to each subject's own T1-weighted MRI for the segmentation of GM and WM, was used as previously described. 20 The global cortical PiB retention standard uptake value ratio (SUVr), with cerebellar GM uptake as the reference, was obtained from the bilateral parietal (including posterior cingulate and precuneus), temporal, prefrontal, orbitofrontal, and anterior cingulate GM regions. Participants were classified as PiB positive or negative using a global cortical-to-cerebellar ratio cutoff point of 1.42. 21 Segmented WMH and the WM masks from FLAIR images in the subject's T1-weighted MRI space mentioned above were used to derive the regional WM PiB SUVr for the WMH and the normal-appearing white matter (NAWM), from the PiB-PET images registered to subject's own T1-weighted MRI.
Statistical analyses
We described the demographic, clinical, and imaging characteristics of subjects in the control and MS groups using mean values and SDs for continuous variables and counts and percentages for categorical variables. p values comparing the control and MS groups were obtained using conditional logistic regression models to account for the matched case/ control design. Associations of the imaging characteristics with cognitive function were additionally adjusted for WMH volume, and thalamic volume was further adjusted for total intracranial volume (see supplement).
Results
Demographic and clinical characteristics
Of the 24 patients, 14 had relapsing-remitting and 9 had progressive MS ( Table 1) . One was unclassifiable. A subset of 16 patients had brain MRI, and 12 of the 16 with brain MRI also had PiB-PET. Except for an unexplained paucity of hypertension in MS, the groups did not differ in sex distribution, age at cognitive testing, age at imaging, APOE ε4 carrier status, education level, or atherosclerosis-associated risk factors of WMH accumulation (p > 0.05). 22 or clinical dementia ratings did not differ between groups (p > 0.05) ( Table 1) . MS group had lower z-scores in the memory (p = 0.03) and language (p = 0.02) domains than controls. In the MS group, one patient fulfilled criteria for MCI and another patient fulfilled criteria for dementia. 6 None of the control individuals had MCI or dementia. The individual cognitive domain z-scores of these two patients are shown in Table 1 .
Cognitive testing Short Test of Mental Status scores
MRI characteristics
Expectedly, total WMH volume (corrected for total intracranial volume) was higher in patients with MS compared to the controls (p = 0.001) ( Table 2) . Median individual lesion volumes were not different between MS patients (23.9 mm 3 ; interquartile range = 10.6-82.5 mm 3 ) and controls (21.3 mm 3 ; interquartile range = 10.6-58.5 mm 3 ) (Wilcoxon rank-sum test; p = 0.23) suggesting that any influence of partial volume averaging on WMH PiB SUVr measurements in these two groups was similar.
Greater WMH volume correlated with lower scores in all domains of cognitive performance but mainly with lower global z-scores (MS-correlation coefficient: −0.57, p = 0.03; controls-correlation coefficient: −0.29; p = 0.01) and lower attention-executive z-scores (MS-correlation coefficient: −0.56, p = 0.04; controls-correlation coefficient: −0.43; p < 0.01). Although the correlations appeared to be stronger in MS patients compared to controls, the differences were not statistically significant (p > 0.05). 
Cortical PiB SUVr (β-amyloid deposition) characteristics
There was no difference in global cortical PiB SUVr between patients with MS and controls in unadjusted (p = 0.35) or WMH volume-adjusted models (p = 0.49) ( Table 2 ). However, using the cortical-to-cerebellar ratio cutoff point of 1.42, 10 controls (17%) had a positive global cortical PiB-PET scan, while all MS patients were negative.
WM PiB SUVr characteristics
In patients with MS, the WMH PiB SUVr (mean ± standard deviation (SD): 1.58 ± 0.18) was lower compared to NAWM PiB SUVr (mean ± SD: 1.66 ± 0.17) (predicted difference ± SD: −0.083 ± 0.022; p = 0.0002) (Figure 4) . Similarly, in controls, the WMH PiB SUVr (mean ± SD: 1.65 ± 0.14) was lower compared to NAWM PiB SUVr (mean ± SD: 1.72 ± 0.14) (predicted difference ± SD: −0.067 ± 0.008; p < 0.0001). Neither WMH PiB SUVrs (predicted difference ± SD: −0.066 ± 0.042; p = 0.121) nor NAWM PiB SUVrs (predicted difference ± SD: −0.050 ± 0.042; p = 0.237) differed between MS and control groups. When corrected for the differential presence of hypertension as a WMH risk factor, the results did not change. Given the small sample size, additional multifactorial analyses were not feasible.
WMH PiB SUVr correlated with visuospatial performance z-scores in patients with MS (correlation coefficient: 0.65; p = 0.02). NAWM PiB SUVr also correlated with visuospatial performance z-scores in patients with MS (correlation coefficient: 0.69; p = 0.01). We did not observe similar correlations among controls, either in the WMH or NAWM PiB SUVrs (>0.05).
In Figure 5 , as follow-up to quantitative analyses presented in Figure 4 , we show MRI and PiB-PET images from 1 patient with MS and 3 controls as visual examples of different densities of WMH risk factors, chosen to have similar PiB SUVrs to avoid a global inter-individual SUVr difference.
Discussion
The frequency of MS (0.5%) in our study is concordant with the prevalence of MS in the same population (0.2%). 23 With a mean age at cognitive and imaging studies in the mid-60s and mean disease duration of 24 years, our study population was representative of a late MS population with also an older than expected age at onset of MS. 23 Patients with earlier MS onset could have been too disabled or already deceased to join the MCSA. The study design enforced a limitation of not allowing us to generalize findings to younger MS, while focusing on "older" MS decreased the likelihood of active MS from confounding our results.
Within the typical age group of MS (younger than 55 years), the main cognitive difficulties are in processing speed, visual learning, and complex sustained attention, while verbal fluency problems affect 25% of MS patients. 24 In our study, patients with late MS performed worse in memory and language domains, while increased WMH load, the hallmark of MS pathology on MRI, was associated with a lower global cognitive performance and decreased attention-executive function.
Late MS is characterized by normal PiB uptake in the cortex
PiB SUVr was calculated using cerebellar GM as the reference region because cerebellum is relatively unaffected by the β-amyloid deposition 7 or at least not as prone to β-pleated sheet configuration of amyloid. 25 However, even the cerebellum is not immune to amyloid pathology completely as can be seen in familial AD as opposed to sporadic AD or controls. 26 Although the validity of cerebellar GM as a reference region for WM PiB uptake analyses was not previously established, we compared the PiB uptake in the cerebellar GM in MS versus matched controls and found no difference, unadjusted (p = 0.37) or adjusted for WMH volume (p = 0.86). Therefore, we conclude that cerebellar GM PiB uptake is an acceptable reference for patients with MS within our study construct.
In the control group, there was evidence of cortical β-amyloid deposition without associated cognitive impairment in 17% of the participants. In contrast, none of the MS patients had a positive cortical PiB-PET scan despite the fact that MS group had worse cognitive performance than the control group. While MS patients can get AD, it seems as if MS itself does not cause β-amyloid pathology in the cortex or having had MS might have been protective from cortical amyloid pathology. However, due to small sample size, one has to be cautious not to over-interpret our results. Alternatively, if PiB strongly binds myelin, thinning of the limited amount of GM myelin could lead to significantenough loss of PiB binding. This could in return overwhelm a possibility to detect β-amyloid accumulation in GM that is otherwise present in older MS patients. Such a possibility of undetectable amyloid presence in the cortex can further be investigated longitudinally by an autopsy series.
Cortical thinning is present even at the first symptomatic manifestation of MS. 27 In our study, most affected regions were the temporal and frontal lobes and the thicker cortical regions compared to the parietal and occipital lobes. The frontal and temporal lobes contain multimodal association areas that, such as the thalamus, are interconnected with multiple cortical areas via a large number of WM tracts prone to damage in MS. Our study supports the previous associations between structural and functional changes in the temporal lobe and cognitive performance in MS. 28 Since the association between temporal lobe cortical thinning in late MS and a lower global cognitive z-score in our study became stronger when corrected for WMH load, it is likely that cortical lesions independently contribute to temporal and frontal atrophy in MS.
There is about twofold increase in the number of lesions detected and with significant more inter-rater agreement in 7-T versus 3-T MRI. 29 As such, 7-T MRI studies identify cortical lesions in 97% of patients with MS 30 and potentially are more suitable for such precise analyses than 3-T MRI studies like ours. Therefore, we specifically did not analyze the impact of cortical lesions in relation to PiB-PET findings. However, our findings suggest that not just the global cortical lesion load but also the distribution of local cortical atrophy should be analyzed in relation to specific cognitive domains in MS.
Previous findings suggest that deep GM and especially thalamic atrophy is a structural marker associated with cognitive processing difficulties in MS. 31, 32 Loss of thalamic volume may reflect a reduction in neuronal density due to cell-intrinsic mechanisms, loss of anterograde and retrograde connectivity due to WM lesions, or combination thereof. 33, 34 We show that thalamic volume correlates with performance in attention-executive function in MS, highlighting role of thalamus in attention. 35 The weakening of this correlation after correcting for WMH load suggests that the involvement of thalamo-cortical projections, rather than a direct thalamic involvement alone, is the likely driver of this association. PiB-PET can potentially be utilized to study the association between these projections and cognitive function in MS.
Reduced PiB uptake in the WM as a potential global marker of WM integrity is associated with decreased visuospatial performance
PET is a promising alternative for myelin imaging. 9, 10, 12, 13, 36, 37 Human PET studies highlighted the potential sensitivity of PiB in detecting WM integrity 11 and its reliability for use in longitudinal evaluations. 38 PiB uptake in WM was partly explained by binding of PiB to the beta-sheet structure of myelin basic protein, 11 which is degraded in WMH of various causes including MS. 39 A micro-PET study showed a high sensitivity for PiB in detecting remyelination in lysolecithin-induced rat demyelination model. 13 In MS, a reduction in PiB uptake is more prominent in periventricular WM lesions. 40 Consistent with previous studies, 9, 41 we demonstrated that PiB differentiated WMH from NAWM. The reduction in PiB uptake in WMH compared to NAWM may be a result in disruption of the beta-sheet structure or a measure of total amount of myelin loss. As presented in individual examples, WM lesions in the patient with MS and additional WMH risk factors were associated with practically absent PiB uptake when compared to individuals with non-MS WMH risk factors alone. As expected from this observation, there was an intriguingly lower PiB uptake within WMH in MS than in controls within the sample size limits.
While the static PiB-PET quantification approach provides higher WM/grey matter contrast it also shows poor reproducibility compared to a dynamic approach. 38 A static SUVr method was preferred over dynamic sampling for two reasons. Dynamic scanning requires much longer camera time and hence is much more expensive and therefore not feasible in a population-based study of thousands of individuals like the MCSA. Longer scan times impose much greater subject burden making it not feasible for a volunteer-based longitudinal study such as ours.
Per the original MRI protocol, we did not obtain gadolinium-T1 imaging and did not study the association between PiB binding and active MS lesions. It likely would not have mattered since the frequency of gadolinium enhancing lesions decrease dramatically after 40 years of age. 42 Visuospatial processing requires one of the largest network organizations of the central nervous system with relatively long tracts connecting parietal multimodal association areas to lateral prefrontal cortex and medial inferior temporal cortices with occipital lobes. Therefore, this network would be very prone to disruption by WM damage. In MS, WM damage is not limited to lesions and can be seen in the NAWM. We found that PiB uptake in areas of WMH and NAWM correlated with visuospatial performance in MS. Visuospatial processing changes in MS probably reflect disrupted neuronal connectivity in association areas due to WM damage reflected in PiB-PET measurements. While our finding highlights the potential sensitivity of PiB-PET in detecting overall WM damage in MS, the final interpretation will require confirmation in a larger number of cases, younger patients, and longitudinal studies.
